Evidence map›Paper›PMID 32533369›Full record

ArticleJournal of computer-aided molecular design2021

Predicting reactivity to drug metabolism: beyond P450s-modelling FMOs and UGTs.

Mario Öeren, Peter J Walton, Peter A Hunt, David J Ponting, Matthew D Segall

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. In Silico Tools and Software to Predict ADMET of New Drug Candidates.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mario ÖerenOptibrium Limited, Cambridge Innovation Park, Denny End Road, Cambridge, CB25 9PB, UK. mario@optibrium.com.ORCID 0000-0003-4292-5557
Peter J WaltonOptibrium Limited, Cambridge Innovation Park, Denny End Road, Cambridge, CB25 9PB, UK.
Peter A HuntOptibrium Limited, Cambridge Innovation Park, Denny End Road, Cambridge, CB25 9PB, UK.
David J PontingLhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.
Matthew D SegallOptibrium Limited, Cambridge Innovation Park, Denny End Road, Cambridge, CB25 9PB, UK.
Optibrium (United Kingdom) · GBUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a study based on density functional theory calculations to explore the rate limiting steps of product formation for oxidation by Flavin-containing Monooxygenase (FMO) and glucuronidation by the UDP-glucuronosyltransferase (UGT) family of enzymes. FMOs are responsible for the modification phase of metabolism of a wide diversity of drugs, working in conjunction with Cytochrome P450 (CYP) family of enzymes, and UGTs are the most important class of drug conjugation enzymes. Reactivity calculations are important for prediction of metabolism by CYPs and reactivity alone explains around 70-85% of the experimentally observed sites of metabolism within CYP substrates. In the current work we extend this approach to propose model systems which can be used to calculate the activation energies, i.e. reactivity, for the rate-limiting steps for both FMO oxidation and glucuronidation of potential sites of metabolism. These results are validated by comparison with the experimentally observed reaction rates and sites of metabolism, indicating that the presented models are suitable to provide the basis of a reactivity component within generalizable models to predict either FMO or UGT metabolism.

Indexed as

Cytochrome P-450 Enzyme SystemGlucuronosyltransferaseHumansInactivation, MetabolicModels, BiologicalModels, MolecularOxidation-ReductionOxygenasesPharmaceutical PreparationsCytochrome P-450 Enzyme Systemdimethylaniline monooxygenase (N-oxide forming)GlucuronosyltransferaseOxygenasesPharmaceutical PreparationsDFTFMOGlucuronidationOxidationReactivityUGT

Identifiers

PMID32533369
OpenAlexW3035372176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.